CoChat

The Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 Inhibits Lipopolysaccharide-Induced Osteoclast Formation and Bone Resorption via Inhibition of TNF- α Expression in Macrophages

Open access

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Glucagon-like peptide-1 (GLP-1) receptor agonists are an effective treatment approach for type 2 diabetes. Recently, anti-inflammatory effects of GLP-1 receptor agonists have also been reported. Lipopolysaccharide (LPS) induces inflammation and osteoclast formation. In this study, we investigated the effect of exendin-4, a widely used GLP-1 receptor agonist, in LPS-induced osteoclast formation and bone resorption. LPS with or without exendin-4 was administered on mouse calvariae by daily subcutaneous injection. The number of osteoclasts, the ratio of bone resorption pits, and the level of C-terminal cross-linked telopeptide of type I collagen (CTX) were significantly lower in LPS- and exendin-4-coadministered mice than in mice administered with LPS alone. RANKL and TNF- α mRNA expression levels were lower in the exendin-4- and LPS-coadministered group than in the LPS-administered group. Our in vitro results showed no direct effects of exendin-4 on RANKL-induced osteoclast formation, TNF- α -induced osteoclast formation, or LPS-induced RANKL expression in stromal cells. Conversely, TNF- α mRNA expression was inhibited in the exendin-4- and LPS-cotreated macrophages compared with cells treated with LPS alone. These results indicate that the GLP-1 receptor agonist exendin-4 may inhibit LPS-induced osteoclast formation and bone resorption by inhibiting LPS-induced TNF- α production in macrophages.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2018/5783639

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 In vivo effect of exendin-4 on lipopolysaccharide- (LPS-) induced osteoclast formation. (a) Histological sections of mouse calvariae after 5-day daily supracalvarial injections with phosphate-buffered saline (PBS), LPS (100 μg/day), LPS (100 μg/day) with exendin-4 (20 μg/day), and exendin-4 (20 μg/day). Tartrate-resistant acid phosphatase (TRAP) staining and hematoxylin counterstaining were performed. TRAP-positive cells were stained dark red. (b) The numbers of TRAP-positive cells in the suture mesenchyme of calvaria from the mouse groups administered with PBS, LPS, LPS with exendin-4, and exendin-4, respectively. Data is expressed as means ± standard deviation (SD). Statistical significance were determined by Scheffe's test (n = 4; ∗∗p < 0.01).
Figure 1 In vivo effect of exendin-4 on lipopolysaccharide- (LPS-) induced osteoclast formation. (a) Histological sections of mouse calvariae after 5-day daily supracalvarial injections with phosphate-buffered saline (PBS), LPS (100 μg/day), LPS (100 μg/day) with exendin-4 (20 μg/day), and exendin-4 (20 μg/day). Tartrate-resistant acid phosphatase (TRAP) staining and hematoxylin counterstaining were performed. TRAP-positive cells were stained dark red. (b) The numbers of TRAP-positive cells in the suture mesenchyme of calvaria from the mouse groups administered with PBS, LPS, LPS with exendin-4, and exendin-4, respectively. Data is expressed as means ± standard deviation (SD). Statistical significance were determined by Scheffe's test (n = 4; ∗∗p < 0.01).CC BY · PubMed Central
Figure 2 Exendin-4 inhibited LPS-induced bone resorption in vivo. (a) 3D reconstructed images of calvariae from micro-CT scanning. Mice were subjected to 5-day daily subcutaneous injections on the calvariae with PBS, LPS (100 μg/day) with or without exendin-4 (20 μg/day), and exendin-4 (20 μg/day), and calvariae were excised on the sixth day. The red dots indicate areas of bony destruction. (b) Ratio of bone destruction area to total bone area. Data is expressed as means ± SD (n = 4; ∗p < 0.05, ∗∗p < 0.01). The statistical significance of differences was determined by Scheffe's test. (c) Serum levels of C-terminal telopeptide of type I collagen (CTX) determined by a mouse CTX assay kit. Data is expressed as means ± SD. The statistical significance of differences was determined using Scheffe's test (n = 4; ∗∗p < 0.01).
Figure 2 Exendin-4 inhibited LPS-induced bone resorption in vivo. (a) 3D reconstructed images of calvariae from micro-CT scanning. Mice were subjected to 5-day daily subcutaneous injections on the calvariae with PBS, LPS (100 μg/day) with or without exendin-4 (20 μg/day), and exendin-4 (20 μg/day), and calvariae were excised on the sixth day. The red dots indicate areas of bony destruction. (b) Ratio of bone destruction area to total bone area. Data is expressed as means ± SD (n = 4; ∗p < 0.05, ∗∗p < 0.01). The statistical significance of differences was determined by Scheffe's test. (c) Serum levels of C-terminal telopeptide of type I collagen (CTX) determined by a mouse CTX assay kit. Data is expressed as means ± SD. The statistical significance of differences was determined using Scheffe's test (n = 4; ∗∗p < 0.01).CC BY · PubMed Central
Figure 3 Exendin-4 suppressed expression of LPS-induced tumor necrosis factor- (TNF-) α and receptor activator of NF-kB ligand (RANKL) in vivo. TNF-α and RANKL mRNA levels in mouse calvariae were determined using real-time RT-PCR. Total RNA was isolated from mouse calvariae after 5-day daily supracalvarial injections with PBS, LPS (100 μg/day) with or without exendin-4 (20 μg/day), and exendin-4 alone (20 μg/day). TNF-α and RANKL mRNA levels were normalized to the expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Data is expressed as means ± SD. The statistical significance of differences was determined using Scheffe's test (n = 4; ∗p < 0.05, ∗∗p < 0.01).
Figure 3 Exendin-4 suppressed expression of LPS-induced tumor necrosis factor- (TNF-) α and receptor activator of NF-kB ligand (RANKL) in vivo. TNF-α and RANKL mRNA levels in mouse calvariae were determined using real-time RT-PCR. Total RNA was isolated from mouse calvariae after 5-day daily supracalvarial injections with PBS, LPS (100 μg/day) with or without exendin-4 (20 μg/day), and exendin-4 alone (20 μg/day). TNF-α and RANKL mRNA levels were normalized to the expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Data is expressed as means ± SD. The statistical significance of differences was determined using Scheffe's test (n = 4; ∗p < 0.05, ∗∗p < 0.01).CC BY · PubMed Central
Figure 4 Exendin-4 had no effect on RANKL-induced osteoclast formation, TNF-α-induced osteoclast formation, osteoclast precursor cell viability, or LPS-induced RANKL expression in stromal cells in vitro. (a) Microscopic images and numbers of TRAP-positive cells. Osteoclast precursors were treated with macrophage colony-stimulating factor (M-CSF) alone, M-CSF with RANKL, M-CSF with RANKL and exendin-4, and M-CSF with exendin-4 for 5 days, then stained with TRAP solution. (b) Microscopic images and numbers of TRAP-positive cells. Osteoclast precursors were treated with M-CSF alone, M-CSF with TNF-α, M-CSF with TNF-α and exendin-4, and M-CSF with exendin-4 for 5 days, then stained with TRAP solution. (c) Cell viability of osteoclast precursor cells treated with M-CSF alone and M-CSF with exendin-4 for 5 days. Cell viability was determined by cell counting kit-8. Data is presented as percentage activity relative to the activity in the culture with M-CSF alone and is expressed as means ± SD. (d) RANKL mRNA expression levels in stromal cells determined by real-time RT-PCR method. Total RNA was extracted from stromal cells that were cultured with PBS, LPS with or without exendin-4, and exendin-4 alone, respectively. RANKL mRNA levels were normalized to that of GAPDH. Statistical significance of differences was determined by Scheffe's test (n = 4; ∗∗P < 0.01).
Figure 4 Exendin-4 had no effect on RANKL-induced osteoclast formation, TNF-α-induced osteoclast formation, osteoclast precursor cell viability, or LPS-induced RANKL expression in stromal cells in vitro. (a) Microscopic images and numbers of TRAP-positive cells. Osteoclast precursors were treated with macrophage colony-stimulating factor (M-CSF) alone, M-CSF with RANKL, M-CSF with RANKL and exendin-4, and M-CSF with exendin-4 for 5 days, then stained with TRAP solution. (b) Microscopic images and numbers of TRAP-positive cells. Osteoclast precursors were treated with M-CSF alone, M-CSF with TNF-α, M-CSF with TNF-α and exendin-4, and M-CSF with exendin-4 for 5 days, then stained with TRAP solution. (c) Cell viability of osteoclast precursor cells treated with M-CSF alone and M-CSF with exendin-4 for 5 days. Cell viability was determined by cell counting kit-8. Data is presented as percentage activity relative to the activity in the culture with M-CSF alone and is expressed as means ± SD. (d) RANKL mRNA expression levels in stromal cells determined by real-time RT-PCR method. Total RNA was extracted from stromal cells that were cultured with PBS, LPS with or without exendin-4, and exendin-4 alone, respectively. RANKL mRNA levels were normalized to that of GAPDH. Statistical significance of differences was determined by Scheffe's test (n = 4; ∗∗P < 0.01).CC BY · PubMed Central
Figure 5 Exendin-4 inhibited LPS-induced expression of TNF-α in macrophages. TNF-α mRNA levels in macrophages were detected by real-time RT-PCR. Total RNA was isolated from macrophages cultured with PBS, LPS with or without exendin-4, and exendin-4 alone. TNF-α mRNA levels were normalized to the levels of GAPDH. Statistical significance of differences was determined by Scheffe's test (n = 4; ∗p < 0.05, ∗∗P < 0.01).
Figure 5 Exendin-4 inhibited LPS-induced expression of TNF-α in macrophages. TNF-α mRNA levels in macrophages were detected by real-time RT-PCR. Total RNA was isolated from macrophages cultured with PBS, LPS with or without exendin-4, and exendin-4 alone. TNF-α mRNA levels were normalized to the levels of GAPDH. Statistical significance of differences was determined by Scheffe's test (n = 4; ∗p < 0.05, ∗∗P < 0.01).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Research works printed but not linked: 1

  1. 2003, Current Opinion in Investigational Drugs, 4, 401

Cited by

See all 45

Metadata

Authors
Shen, W.-R., Kimura, K., Ishida, M., Sugisawa, H., Kishikawa, A., Shima, K., Ogawa, S., Qi, J., & Kitaura, H.
Affiliations
Tohoku University (JP)
Corresponding author
Kitaura, Hideki
Venue
Journal of Immunology Research
Publisher
Wiley
Published
2018
Volume
2018
Issue
5783639
Pages
1-10
ISSN
  • 2314-7156 (ISSN-L)
  • 2314-8861
OpenAlex
W2789846563
Cited by
45
References
46
Citations by year
2026: 5 · 2025: 8 · 2024: 5 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 8 · 2019: 7
FWCI
1.78
Type
journal article
Language
en
Open access
Locations
  • Journal of Immunology Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Japan Society for the Promotion of Science (16K11776)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
exendin-4, GLP-1 receptor agonists, osteoclastogenesis, bone resorption, lipopolysaccharide, TNF-α, macrophages, RANKL, anti-inflammatory activity, type 2 diabetes, calvaria, CTX
MeSH terms
Glucagon-Like Peptide-1 Receptor, Exenatide, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Anti-Inflammatory Agents, Bone Resorption, Cell Differentiation, Cells, Cultured, Diabetes Mellitus, Type 2, Lipopolysaccharides, Macrophages, Male, Mice, Inbred C57BL, Osteoclasts, Peptides, Tumor Necrosis Factor-alpha, Venoms, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 Inhibits Lipopolysaccharide-Induced Osteoclast Formation and Bone Resorption via Inhibition of TNF- α Expression in Macrophages. https://app.cochat.ai/papers/10.1155/2018/5783639
The paper
Shen, W.-R., Kimura, K., Ishida, M., Sugisawa, H., Kishikawa, A., Shima, K., Ogawa, S., Qi, J., & Kitaura, H. (2018). The Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 Inhibits Lipopolysaccharide-Induced Osteoclast Formation and Bone Resorption via Inhibition of TNF- α Expression in Macrophages. Journal of Immunology Research. https://doi.org/10.1155/2018/5783639

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.